CTT Pharma CEO Ryan Khouri reports purchase of 9,800 shares worth $479.22
CTTH•CEO share purchase
- CTT Pharmaceutical Holdings CEO Ryan Khouri bought 9,800 CTTH shares at USD 0.05 each.
- Direct holdings increased to 9.4 million shares following the purchase.




